Ningbo Huaxiang Electronic Co., Ltd. (002048) Report Interpretation

Overview

This earnings update examines Ningbo Huaxiang's stabilization amid weak automotive demand and supply-chain inflation. Morgan Stanley sees better underlying profitability and longer-term robotics potential, but lower demand assumptions lead it to cut estimates and its DCF-based target price while maintaining Equal-weight.

Core views

Morgan Stanley characterizes the latest results as mixed. In 2Q26, revenue declined 23% year-on-year to Rmb5.1bn and fell 2% sequentially, reflecting an industry slowdown and a high 2Q25 comparison base associated with the European-business transaction. Despite weaker sales, the report sees stabilization in the underlying business. The disposal of loss-making European operations, a greater focus on domestic operations and modest improvement in North America supported a 2.6ppt year-on-year and 4.8ppt quarter-on-quarter expansion in gross margin. Excluding one-off disposal losses, adjusted NPAT grew by more than 20% year-on-year. The institution nevertheless expects operating pressure to persist in 2H26. Weak end-demand, the gradual pass-through of rising costs and lagged supply-chain inflation are expected to weigh on revenue and costs. The revised forecast therefore lowers revenue by 13.0%, 18.1% and 18.3% for 2026E, 2027E and 2028E, respectively. Morgan Stanley raises gross-margin assumptions by 0.7ppt, 0.7ppt and 0.9ppt over those years because it believes the restructured business mix should support profitability; this partly cushions the impact on earnings, leaving NPAT forecast reductions of 11.3%, 17.2% and 14.0%. The report views humanoid robotics as a longer-term growth option rather than a near-term solution to the auto-cycle pressure. Huaxiang is pursuing manufacturing, follow-on development and components opportunities with domestic and overseas robot manufacturers. Management expects approximately Rmb200mn of robotics revenue in 2026, which remains small compared with the group's Rmb26bn of 2025 revenue. Morgan Stanley believes meaningful contribution will take time and that continued R&D investment is required, but considers successful expansion a potential longer-term growth driver. Morgan Stanley retains a DCF valuation framework because it considers the approach better suited to capturing the company's potential growth capital expenditure. The model uses a 3.3% risk-free rate, 1.5x beta, 8% China equity risk premium and 13.3% WACC; the long-term growth assumption is 5%. The lower demand and revenue outlook reduces the DCF-based target price to Rmb22.80 from Rmb28.50. The report describes the valuation as reasonable at 11x, near the lower end of the historical 6-23x range, and sees relatively limited downside given stabilized operations and improved profitability. In the base case, demand and revenue remain subdued, supply-chain inflation continues to pressure costs, domestic-OEM market share rises, and foreign-brand JV contributions decline. Overseas losses, including North America, are assumed to remain contained and gradually decrease. The base-case target implies 13.0x 2026E P/E. The bull case assumes stable auto operations, deeper robotics partnerships, timely product launches and stronger exports; it applies 23x 2026E P/E and produces a Rmb40.20 valuation. The bear case assumes continued pricing pressure through 2H26, ongoing North American losses and delayed robotics profitability, applying 6x 2026E P/E for a Rmb10.50 valuation.

Analysis framework

Morgan Stanley first assesses the 2Q26 revenue-and-margin outcome, then links operational changes and industry conditions to revised revenue, margin and earnings forecasts. It values the company with a DCF model and supplements this with base, bull and bear cases using 2026E P/E multiples to illustrate the range of outcomes.

Methodology notes

• Valuation methodsDCF (Discounted Cash Flow)

  Discounted cash flow valuation

  The report discounts projected free cash flow using a 13.3% WACC to capture the value of Huaxiang's expected growth capital expenditure and derive its base-case target price.

• Valuation methodsP/E and PEG Valuation

  2026E P/E scenario valuation

  Morgan Stanley cross-checks scenario outcomes using 2026E P/E multiples of 23x in the bull case, 13.0x in the base case and 6x in the bear case.

• Industry AnalysisSupply-demand framework

  Demand and cost-pressure analysis

  The report attributes near-term pressure to subdued end-demand and supply-chain inflation, while examining how business restructuring and domestic-market exposure affect margins.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Ningbo Huaxiang Electronic Co., Ltd. (002048.SZ)

  Primary covered company; auto-parts supplier pursuing domestic OEM penetration, exports and humanoid robotics expansion.

  Strengths

  Improving gross margins, stabilization following European restructuring, domestic OEM share-gain potential and longer-term robotics optionality.

  Weaknesses

  Subdued demand, weaker foreign-brand JV contribution and a robotics business that remains too small to materially support near-term earnings.

  Comparison

  The report describes valuation at about 11x as near the lower end of its historical 6-23x range.

  Risks

  Pricing pressure, supply-chain cost inflation, overseas operating losses and delayed robotics profitability.

Key data

• 2Q26 revenueRmb5.1bnDown 23% year-on-year and 2% quarter-on-quarter.
• 2Q26 gross-margin change+2.6ppt YoY; +4.8ppt QoQSupported by the disposal of loss-making European operations and greater domestic focus.
• 2Q26 adjusted NPATMore than +20% YoYExcludes one-off disposal losses.
• 2026-28 revenue forecast revisions-13.0%, -18.1%, -18.3%Reflects weaker demand assumptions.
• 2026-28 NPAT forecast revisions-11.3%, -17.2%, -14.0%Margin improvement partly offsets revenue pressure.
• 2026 robotics revenue expectationApproximately Rmb200mnSmall relative to Rmb26bn of group revenue in 2025.
• Base-case target priceRmb22.80Reduced from Rmb28.50; implies 13.0x 2026E P/E.
• DCF WACC13.3%Based on a 3.3% risk-free rate, 1.5x beta and 8% China equity risk premium.

Impact & implications

The report argues that restructuring has improved the quality of Huaxiang's earnings even as automotive demand weakens. Its neutral rating reflects the balance between limited perceived downside, domestic share-gain potential and robotics optionality on one hand, and lower revenue expectations, cost inflation, foreign-brand JV declines and overseas-loss risk on the other.

Risks

• Rapid share losses by foreign brands in China could negatively affect Huaxiang.
• Cost inflation associated with penetrating local brands could be greater than expected.
• Overseas losses, particularly in North America, could persist longer than expected.
• Persistent pricing pressure through 2H26 could constrain profitability.
• Humanoid robotics development could be prolonged, with no meaningful medium-term profit contribution.

What to watch

• China passenger-vehicle sales growth.
• A turnaround in overseas operations.
• Potential acquisitions, including in car seating.
• Acceleration of the robotics business.
• Sales growth to domestic key customers and the sustainability of sales from traditional global players in China.